Cardiovascular Diabetology (Jun 2012)

The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively

  • Mazurek Michal,
  • Kowalczyk Jacek,
  • Lenarczyk Radoslaw,
  • Zielinska Teresa,
  • Sedkowska Agnieszka,
  • Pruszkowska-Skrzep Patrycja,
  • Swiatkowski Andrzej,
  • Sredniawa Beata,
  • Kowalski Oskar,
  • Polonski Lech,
  • Strojek Krzysztof,
  • Kalarus Zbigniew

DOI
https://doi.org/10.1186/1475-2840-11-78
Journal volume & issue
Vol. 11, no. 1
p. 78

Abstract

Read online

Abstract Background Diabetes (DM) deteriorates the prognosis in patients with coronary heart disease. However, the prognostic value of different glucose abnormalities (GA) other than DM in subjects with acute myocardial infarction (AMI) treated invasively remains unclear. Aims To assess the incidence and impact of GA on clinical outcomes in AMI patients treated with percutaneous coronary intervention (PCI). Methods A single-center, prospective registry encompassed 2733 consecutive AMI subjects treated with PCI. In all in-hospital survivors (n = 2527, 92.5%) without the history of DM diagnosed before or during index hospitalization standard oral glucose tolerance test (OGTT) was performed during stable condition before hospital discharge and interpreted according to WHO criteria. The mean follow-up period was 37.5 months. Results The incidence of GA was as follows: impaired fasting glycaemia - IFG (n = 376, 15%); impaired glucose tolerance - IGT (n = 560, 22%); DM (n = 425, 17%); new onset DM (n = 384, 15%); and normal glucose tolerance – NGT (n = 782, 31%). During the long-term follow-up, death rate events for previously known DM, new onset DM and IGT were significantly more frequent than those for IFG and NGT (12.3; 9.6 and 9.4 vs. 5.6 and 6.4%, respectively, P Conclusions Glucose abnormalities are very common in AMI patients. DM, new onset DM and IGT increase remote mortality. Impaired glucose tolerance bears similar long-term prognosis as diabetes.

Keywords